Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose
Today, the U.S. Food and Drug Administration changed the emergency situation usage permissions (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to license bivalent solutions of the vaccines for usage as a single booster dosage at least 2 months following main or booster vaccination. The bivalent vaccines, which we will likewise describe as “upgraded boosters,” include 2 messenger RNA (mRNA) parts of SARS-CoV-2 infection, among the initial stress of SARS-CoV-2 and the other one in typical in between the bachelor’s degree.4 and bachelor’s degree.5 family trees of the omicron version of SARS-CoV-2.
The Moderna COVID-19 Vaccine, Bivalent, is licensed for usage as a single booster dosage in people 18 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is licensed for usage as a single booster dosage in people 12 years of age and older.
The monovalent COVID-19 vaccines that are licensed or authorized by the FDA and have actually been administered to countless individuals in the United States considering that December 2020 consist of an element from the initial stress of SARS-CoV-2.
#covid #vaccine #covid19
Study:
https://covid19globalcases.com/bivalent-covid-19-booster-vaccine-coronavirus-covid-19-update/
Comments
Post a Comment